Stemness kinase

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S8572 Amcasertib (BBI503) <1 mg/mL 14 mg/mL 1 mg/mL
Catalog No. Information Product Use Citations Product Validations

Amcasertib (BBI503)

Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.

Tags: Stemness kinase Inhibition | Stemness kinase Activation | Stemness kinase Inhibitor | Stemness kinase activator | Stemness kinase Activity | Stemness kinase phosphorylation| CSC pathway